145 related articles for article (PubMed ID: 10571246)
1. Mechanism of inhibition of P-glycoprotein-mediated drug transport by protein kinase C blockers.
Castro AF; Horton JK; Vanoye CG; Altenberg GA
Biochem Pharmacol; 1999 Dec; 58(11):1723-33. PubMed ID: 10571246
[TBL] [Abstract][Full Text] [Related]
2. Partial reversal of multidrug resistance in human breast cancer cells by an N-myristoylated protein kinase C-alpha pseudosubstrate peptide.
Gupta KP; Ward NE; Gravitt KR; Bergman PJ; O'Brian CA
J Biol Chem; 1996 Jan; 271(4):2102-11. PubMed ID: 8567666
[TBL] [Abstract][Full Text] [Related]
3. Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance.
Gekeler V; Boer R; Uberall F; Ise W; Schubert C; Utz I; Hofmann J; Sanders KH; Schächtele C; Klemm K; Grunicke H
Br J Cancer; 1996 Sep; 74(6):897-905. PubMed ID: 8826855
[TBL] [Abstract][Full Text] [Related]
4. Partial inhibition of multidrug resistance by safingol is independent of modulation of P-glycoprotein substrate activities and correlated with inhibition of protein kinase C.
Sachs CW; Safa AR; Harrison SD; Fine RL
J Biol Chem; 1995 Nov; 270(44):26639-48. PubMed ID: 7592889
[TBL] [Abstract][Full Text] [Related]
5. Differential modulation of P-glycoprotein transport by protein kinase inhibition.
Bates SE; Lee JS; Dickstein B; Spolyar M; Fojo AT
Biochemistry; 1993 Sep; 32(35):9156-64. PubMed ID: 7690250
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C effectors bind to multidrug ABC transporters and inhibit their activity.
Conseil G; Perez-Victoria JM; Jault JM; Gamarro F; Goffeau A; Hofmann J; Di Pietro A
Biochemistry; 2001 Feb; 40(8):2564-71. PubMed ID: 11327879
[TBL] [Abstract][Full Text] [Related]
7. Potent induction of human colon cancer cell uptake of chemotherapeutic drugs by N-myristoylated protein kinase C-alpha (PKC-alpha) pseudosubstrate peptides through a P-glycoprotein-independent mechanism.
Bergman PJ; Gravitt KR; Ward NE; Beltran P; Gupta KP; O'Brian CA
Invest New Drugs; 1997; 15(4):311-8. PubMed ID: 9547673
[TBL] [Abstract][Full Text] [Related]
8. Loss of cyclosporin and azidopine binding are associated with altered ATPase activity by a mutant P-glycoprotein with deleted phe(335).
Chen KG; Lacayo NJ; Durán GE; Cohen D; Sikic BI
Mol Pharmacol; 2000 Apr; 57(4):769-77. PubMed ID: 10727524
[TBL] [Abstract][Full Text] [Related]
9. Effects of sphingosine stereoisomers on P-glycoprotein phosphorylation and vinblastine accumulation in multidrug-resistant MCF-7 cells.
Sachs CW; Ballas LM; Mascarella SW; Safa AR; Lewin AH; Loomis C; Carroll FI; Bell RM; Fine RL
Biochem Pharmacol; 1996 Aug; 52(4):603-12. PubMed ID: 8759033
[TBL] [Abstract][Full Text] [Related]
10. PKC-independent modulation of multidrug resistance in cells with mutant (V185) but not wild-type (G185) P-glycoprotein by bryostatin 1.
Spitaler M; Utz I; Hilbe W; Hofmann J; Grunicke HH
Biochem Pharmacol; 1998 Oct; 56(7):861-9. PubMed ID: 9774148
[TBL] [Abstract][Full Text] [Related]
11. Effects of protein kinase C modulators on multidrug resistance in human glioma cells.
Matsumoto T; Tani E; Yamaura I; Miyaji K; Kaba K
Neurosurgery; 1995 Mar; 36(3):565-71; discussion 572. PubMed ID: 7538636
[TBL] [Abstract][Full Text] [Related]
12. Dexniguldipine hydrochloride, a protein-kinase-C-specific inhibitor, affects the cell cycle, differentiation, P-glycoprotein levels, and nuclear protein phosphorylation in Friend erythroleukemia cells.
Patterson KK; Beckman BS; Klotz DM; Mallia CM; Jeter JR
J Cancer Res Clin Oncol; 1996; 122(8):465-75. PubMed ID: 8698746
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of P-glycoprotein by PKA and PKC modulates swelling-activated Cl- currents.
Vanoye CG; Castro AF; Pourcher T; Reuss L; Altenberg GA
Am J Physiol; 1999 Feb; 276(2):C370-8. PubMed ID: 9950764
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase C-mediated phosphorylation of the human multidrug resistance P-glycoprotein regulates cell volume-activated chloride channels.
Hardy SP; Goodfellow HR; Valverde MA; Gill DR; Sepúlveda V; Higgins CF
EMBO J; 1995 Jan; 14(1):68-75. PubMed ID: 7828597
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase C-mediated phosphorylation does not regulate drug transport by the human multidrug resistance P-glycoprotein.
Goodfellow HR; Sardini A; Ruetz S; Callaghan R; Gros P; McNaughton PA; Higgins CF
J Biol Chem; 1996 Jun; 271(23):13668-74. PubMed ID: 8662768
[TBL] [Abstract][Full Text] [Related]
16. Mutations to amino acids located in predicted transmembrane segment 6 (TM6) modulate the activity and substrate specificity of human P-glycoprotein.
Loo TW; Clarke DM
Biochemistry; 1994 Nov; 33(47):14049-57. PubMed ID: 7947814
[TBL] [Abstract][Full Text] [Related]
17. Modulation of P-glycoprotein by protein kinase C alpha in a baculovirus expression system.
Ahmad S; Safa AR; Glazer RI
Biochemistry; 1994 Aug; 33(34):10313-8. PubMed ID: 7915139
[TBL] [Abstract][Full Text] [Related]
18. Interaction of the P-glycoprotein multidrug transporter (MDR1) with high affinity peptide chemosensitizers in isolated membranes, reconstituted systems, and intact cells.
Sharom FJ; Yu X; Lu P; Liu R; Chu JW; Szabó K; Müller M; Hose CD; Monks A; Váradi A; Seprôdi J; Sarkadi B
Biochem Pharmacol; 1999 Aug; 58(4):571-86. PubMed ID: 10413294
[TBL] [Abstract][Full Text] [Related]
19. Characterization of multidrug resistance P-glycoprotein transport function with an organotechnetium cation.
Piwnica-Worms D; Rao VV; Kronauge JF; Croop JM
Biochemistry; 1995 Sep; 34(38):12210-20. PubMed ID: 7547962
[TBL] [Abstract][Full Text] [Related]
20. Synthetic hydrophobic peptides are substrates for P-glycoprotein and stimulate drug transport.
Sharom FJ; Yu X; DiDiodato G; Chu JW
Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):421-8. PubMed ID: 8973548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
